• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前骨骼肌减少症与根治性手术后胰腺癌预后的关系:一项更新的系统评价和荟萃分析。

Association between preoperative sarcopenia and prognosis of pancreatic cancer after curative-intent surgery: a updated systematic review and meta-analysis.

机构信息

Department of Hepatopancreatobiliary Surgery, Shaoxing People's Hospital, Shaoxing, Zhejiang, China.

Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.

出版信息

World J Surg Oncol. 2024 Jan 30;22(1):38. doi: 10.1186/s12957-024-03310-y.

DOI:10.1186/s12957-024-03310-y
PMID:38287345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10825983/
Abstract

BACKGROUND

Sarcopenia is associated with poor outcomes in many malignancies. However, the relationship between sarcopenia and the prognosis of pancreatic cancer has not been well understood. The aim of this meta-analysis was to identify the prognostic value of preoperative sarcopenia in patients with pancreatic cancer after curative-intent surgery.

METHODS

Database from PubMed, Embase, and Web of Science were searched from its inception to July 2023. The primary outcomes were overall survival (OS), progression-free survival (PFS), and the incidence of major complications. The hazard ratio (HR), odds ratio (OR), and 95% confidence intervals (CIs) were used to assess the relationship between preoperative sarcopenia and the prognosis of patients with pancreatic cancer. All statistical analyses were conducted by Review Manager 5.3 and STATA 17.0 software.

RESULTS

A total of 23 retrospective studies involving 5888 patients were included in this meta-analysis. The pooled results demonstrated that sarcopenia was significantly associated with worse OS (HR = 1.53, P < 0.00001) and PFS (HR = 1.55, P < 0.00001). However, this association was not obvious in regard to the incidence of major complications (OR = 1.33, P = 0.11).

CONCLUSION

Preoperative sarcopenia was preliminarily proved to be associated with the terrible prognosis of pancreatic cancer after surgery. However, this relationship needs to be further validated in more prospective studies.

摘要

背景

肌肉减少症与多种恶性肿瘤的不良结局相关。然而,肌肉减少症与胰腺癌预后之间的关系尚未得到充分了解。本荟萃分析的目的是确定术前肌肉减少症对接受根治性手术治疗的胰腺癌患者的预后价值。

方法

从 PubMed、Embase 和 Web of Science 数据库中检索了从其建立到 2023 年 7 月的数据。主要结局指标为总生存期(OS)、无进展生存期(PFS)和主要并发症的发生率。使用风险比(HR)、优势比(OR)和 95%置信区间(CI)来评估术前肌肉减少症与胰腺癌患者预后之间的关系。所有统计分析均使用 Review Manager 5.3 和 STATA 17.0 软件进行。

结果

本荟萃分析共纳入 23 项回顾性研究,涉及 5888 例患者。汇总结果表明,肌肉减少症与较差的 OS(HR=1.53,P<0.00001)和 PFS(HR=1.55,P<0.00001)显著相关。然而,在主要并发症的发生率方面,这种相关性并不明显(OR=1.33,P=0.11)。

结论

术前肌肉减少症初步证明与手术后胰腺癌的不良预后相关。然而,这一关系需要在更多的前瞻性研究中进一步验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b00/10825983/f65d1d89e201/12957_2024_3310_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b00/10825983/fe61caa7fcf0/12957_2024_3310_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b00/10825983/1509be6805e0/12957_2024_3310_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b00/10825983/6ca22ef43106/12957_2024_3310_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b00/10825983/9a976ddc2ba2/12957_2024_3310_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b00/10825983/f65d1d89e201/12957_2024_3310_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b00/10825983/fe61caa7fcf0/12957_2024_3310_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b00/10825983/1509be6805e0/12957_2024_3310_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b00/10825983/6ca22ef43106/12957_2024_3310_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b00/10825983/9a976ddc2ba2/12957_2024_3310_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b00/10825983/f65d1d89e201/12957_2024_3310_Fig5_HTML.jpg

相似文献

1
Association between preoperative sarcopenia and prognosis of pancreatic cancer after curative-intent surgery: a updated systematic review and meta-analysis.术前骨骼肌减少症与根治性手术后胰腺癌预后的关系:一项更新的系统评价和荟萃分析。
World J Surg Oncol. 2024 Jan 30;22(1):38. doi: 10.1186/s12957-024-03310-y.
2
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
3
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.未治疗的霍奇金淋巴瘤患者化疗和放疗在第二原发性恶性肿瘤、总生存期和无进展生存期方面的优化:个体参与者数据分析
Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD008814. doi: 10.1002/14651858.CD008814.pub2.
4
The prognostic value of sarcopenia in oesophageal cancer: A systematic review and meta-analysis.肌肉减少症在食管癌中的预后价值:系统评价和荟萃分析。
J Cachexia Sarcopenia Muscle. 2023 Feb;14(1):3-16. doi: 10.1002/jcsm.13126. Epub 2022 Nov 22.
5
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
6
Bisphosphonates in multiple myeloma: an updated network meta-analysis.双膦酸盐类药物在多发性骨髓瘤中的应用:一项更新的网状Meta分析
Cochrane Database Syst Rev. 2017 Dec 18;12(12):CD003188. doi: 10.1002/14651858.CD003188.pub4.
7
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
8
Sarcopenia and prognosis of advanced cancer patients receiving immune checkpoint inhibitors: A comprehensive systematic review and meta-analysis.癌症进展期患者接受免疫检查点抑制剂治疗的肌肉减少症及其预后:全面系统评价和荟萃分析。
Nutrition. 2021 Oct;90:111345. doi: 10.1016/j.nut.2021.111345. Epub 2021 May 21.
9
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
10
Treatment options for progression or recurrence of glioblastoma: a network meta-analysis.治疗胶质母细胞瘤进展或复发的选择:网络荟萃分析。
Cochrane Database Syst Rev. 2021 May 4;5(1):CD013579. doi: 10.1002/14651858.CD013579.pub2.

引用本文的文献

1
Effects of Sarcopenia on Patient Outcomes in Gastrointestinal Cancer: An Umbrella Review of Published Meta-Analyses.肌肉减少症对胃肠道癌患者预后的影响:已发表的荟萃分析的伞状综述
J Gastrointest Cancer. 2025 Aug 8;56(1):171. doi: 10.1007/s12029-025-01290-0.
2
Synchronous surgery combined preoperative chemotherapy benefits patients suffering pancreatic ductal adenocarcinoma with liver metastases: a systematic review and meta-analysis.同步手术联合术前化疗对伴有肝转移的胰腺导管腺癌患者有益:一项系统评价和荟萃分析
Sci Rep. 2025 Aug 4;15(1):28403. doi: 10.1038/s41598-025-13811-9.
3
Prognostic value of sarcopenia in patients with nasopharyngeal carcinoma: a meta-analysis.

本文引用的文献

1
Early and late recurrence patterns of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: a multicenter study.胰十二指肠切除术后胰腺导管腺癌的早期和晚期复发模式:一项多中心研究。
Int J Surg. 2023 Apr 1;109(4):785-793. doi: 10.1097/JS9.0000000000000296.
2
The differential effects of sarcopenia and cachexia on overall survival for pancreatic ductal adenocarcinoma patients following pancreatectomy: A retrospective study based on a large population.基于大样本的回顾性研究:胰腺导管腺癌患者行胰腺切除术后,肌肉减少症和恶病质对总生存期的差异影响。
Cancer Med. 2023 May;12(9):10438-10448. doi: 10.1002/cam4.5779. Epub 2023 Mar 20.
3
鼻咽癌患者肌肉减少症的预后价值:一项荟萃分析。
Ann Med. 2025 Dec;57(1):2530695. doi: 10.1080/07853890.2025.2530695. Epub 2025 Jul 11.
4
Preoperative CT-derived sarcopenia as a predictor of postoperative complications in patients undergoing laparoscopic radical resection for non-metastatic colorectal cancer: a retrospective study.术前CT衍生的肌肉减少症作为非转移性结直肠癌患者腹腔镜根治性切除术后并发症的预测指标:一项回顾性研究
Int J Colorectal Dis. 2025 Jun 14;40(1):140. doi: 10.1007/s00384-025-04932-8.
5
Comparative study of XGBoost and logistic regression for predicting sarcopenia in postsurgical gastric cancer patients.XGBoost与逻辑回归用于预测胃癌术后患者肌肉减少症的比较研究
Sci Rep. 2025 Apr 14;15(1):12808. doi: 10.1038/s41598-025-98075-z.
6
The prognostic impact of preoperative nutritional status on postoperative complications and overall survival in patients with resectable pancreatic cancer.可切除胰腺癌患者术前营养状况对术后并发症及总生存期的预后影响。
Support Care Cancer. 2025 Mar 3;33(3):240. doi: 10.1007/s00520-025-09303-1.
7
Pre-Operative Markers of Post-Operative Complications in Pancreatic Cancer Patients: A Single-Center Study.胰腺癌患者术后并发症的术前标志物:一项单中心研究。
J Epidemiol Glob Health. 2025 Feb 17;15(1):28. doi: 10.1007/s44197-025-00371-4.
8
Preoperative sarcopenia and postoperative accelerated muscle loss negatively impact survival after resection of locally advanced gastric cancer.术前肌肉减少症和术后加速的肌肉流失对局部晚期胃癌切除术后的生存产生负面影响。
BMC Cancer. 2025 Feb 14;25(1):269. doi: 10.1186/s12885-025-13674-3.
9
CT-based skeletal muscle loss predicts long term prognosis in patients with distal cholangiocarcinoma undergone pancreaticoduodenectomy.基于CT的骨骼肌丢失可预测接受胰十二指肠切除术的远端胆管癌患者的长期预后。
Sci Rep. 2025 Jan 22;15(1):2885. doi: 10.1038/s41598-025-87458-x.
10
Efficacy and safety of neoadjuvant S-1-based chemoradiotherapy in resectable and borderline-resectable pancreatic cancer: a long-term follow-up study.新辅助S-1方案同步放化疗在可切除及交界可切除胰腺癌中的疗效与安全性:一项长期随访研究
World J Surg Oncol. 2024 Dec 20;22(1):336. doi: 10.1186/s12957-024-03609-w.
Low preoperative skeletal muscle index increases the risk of mortality among resectable pancreatic cancer patients: A retrospective study.
术前骨骼肌指数低会增加可切除胰腺癌患者的死亡风险:一项回顾性研究。
World J Gastrointest Surg. 2022 Dec 27;14(12):1350-1362. doi: 10.4240/wjgs.v14.i12.1350.
4
Sarcopenia is an Independent Prognostic Factor in Patients With Pancreatic Cancer - a Meta-analysis.肌肉减少症是胰腺癌患者的独立预后因素 - 一项荟萃分析。
Acad Radiol. 2023 Aug;30(8):1552-1561. doi: 10.1016/j.acra.2022.10.025. Epub 2022 Dec 22.
5
Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma.可切除胰腺导管腺癌患者肌肉减少症和肌内脂肪变性的预后价值。
Korean J Radiol. 2022 Nov;23(11):1055-1066. doi: 10.3348/kjr.2022.0277. Epub 2022 Aug 31.
6
Predicting the Overall Survival in Patients with Advanced Pancreatic Cancer by Calculating L3 Skeletal Muscle Index Derived from CT.基于 CT 计算 L3 骨骼肌指数预测晚期胰腺癌患者的总生存期
Curr Med Imaging. 2022;18(10):1079-1085. doi: 10.2174/1573405618666220303105410.
7
Sarcopenia as a Predictor of Survival in Patients with Pancreatic Adenocarcinoma After Pancreatectomy.肌肉减少症作为胰腺导管腺癌患者胰十二指肠切除术后生存的预测指标
Ann Surg Oncol. 2022 Mar;29(3):1553-1563. doi: 10.1245/s10434-021-10995-y. Epub 2021 Oct 30.
8
Additive Value of Preoperative Sarcopenia and Lymphopenia for Prognosis Prediction in Localized Pancreatic Ductal Adenocarcinoma.术前肌肉减少症和淋巴细胞减少症对局部胰腺导管腺癌预后预测的附加价值
Front Oncol. 2021 May 27;11:683289. doi: 10.3389/fonc.2021.683289. eCollection 2021.
9
The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy.老年胰腺癌患者接受姑息化疗时恶病质和肌肉减少症的影响。
Int J Clin Oncol. 2021 Jul;26(7):1293-1303. doi: 10.1007/s10147-021-01912-0. Epub 2021 Mar 31.
10
Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.胰腺癌一线化疗患者骨骼肌密度和肌肉减少症的临床意义:一项回顾性观察研究。
BMC Cancer. 2021 Jan 18;21(1):77. doi: 10.1186/s12885-020-07753-w.